You are here: Industry Insights > glaucoma

News List

Ocular Therapeutix Announces Topline Results of Phase 3 Clinical Trial of OTX-TP for the Treatment of Glaucoma drugs
May 22, 2019
Ocular Therapeutix Announces Topline Results of Phase 3 Clinical Trial of OTX-TP for the Treatment of Glaucoma.
FDA Approves Rocklatan drugs
March 13, 2019
FDA Approves Rocklatan (netarsudil and latanoprost ophthalmic solution) for the Reduction of Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension.
Glaucoma Burden Increasing Globally but Not Equally drugs
February 27, 2019
The health burden of glaucoma increased globally in the past 25 years and is distributed unequally, according to a study published online Feb. 20 in Acta Ophthalmologica.
Nicox pauses Nasdaq IPO plan amid market volatility fiercebiotech
November 02, 2018
Nicox has pulled out of a planned Nasdaq listing. The French biotech began gearing up to offer stock on Nasdaq earlier this year but has now hit pause on the plan in response to ...
Sun wins approval of glaucoma drug and its once-troubled Halol plant to produce it fiercepharma
September 30, 2018
Sun Pharmaceutical will produce a new eye drug at the plant in Halol after resolving FDA concerns there.
New Research Suggests Glaucoma May Be an Autoimmune Disease drugs
August 13, 2018
The eye disease glaucoma may be an autoimmune disorder, a new study suggests.
Have Glaucoma and Need to Switch Eye Docs? Here's What You Need to Do drugs
August 08, 2018
If you have glaucoma and need to find a new ophthalmologist, creating a personal data portfolio will help ensure a smooth transition in the care of your eye disease.
FDA approves Vyzulta for open-angle glaucoma and ocular hypertension europeanpharmaceuticalreview
November 06, 2017
The FDA has approved a New Drug Application for Vyzulta for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension….
Aerie's glaucoma drug gets strong preliminary FDA opinion pharmafile
October 13, 2017
In a preliminary review of the drug, the FDA has judged that Aerie Pharmaceutical’s experimental glaucoma treatment Rhopressa (netarsudil) effectively reduces intraocular pressure when administered once a day
Gene mutation discovered that can prevent Glaucoma biospectrumasia
July 11, 2017
Singapore-led discovery of rare gene mutation and identification of five new susceptibility loci will help illuminate the disease biology.

Previous page 1 2 3 Next page